Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
AGGRENOX
Generic name / active ingredient
aspirin and extended-release dipyridamole capsules
Dosage-form class
Each combination capsule contains one immediate-release aspirin 25 mg tablet and extended-release dipyridamole 200 mg pellets. The 25 and 200 figures belong to two ingredients, not one 225 mg medicine. Swallow the capsule whole and do not chew or crush it.
Route
Oral
Record reviewed
2026-09-06

Copy from the pack in hand

Source-linked reading points

  • Swallow the capsule whole; do not chew or crush it. Do not self-assemble it from aspirin tablets and immediate-release dipyridamole, open it to divide pellets, discard the white tablet or take only part. Dysphagia requires pharmacist review of an exact alternative product.
  • This combination already contains aspirin. Check active ingredients across prescriptions, OTC pain/cold products and supplements. If another aspirin, anticoagulant, antiplatelet, heparin, fibrinolytic, anagrelide or chronically used NSAID appears, do not self-combine it or assume timing separation removes risk.
  • Vomiting blood or coffee-ground material, black or bloody stool, persistent or uncontrolled bleeding, severe headache with drowsiness, awareness or memory change, loss of consciousness, or new/worsening chest pain requires prompt local medical care; severe acute features require emergency help.
  • Headache is not uncommon after initiation, but the site must not turn the label's clinician-directed alternative into self-adjustment. Severe or intolerable headache, planned pharmacologic stress testing, surgery/dental work, active peptic ulcer, kidney/liver problems, low blood pressure, myasthenia gravis, pregnancy or heavy alcohol use should be disclosed to the responsible team.

Reviewed presentation examples — compare every field

  • Each capsule contains aspirin 25 mg (immediate release) plus dipyridamole 200 mg (extended release); 60-count bottle; not one 225 mg ingredientNDC 0597-0001-60 / NDA 020884
  • Aspirin 25 mg plus extended-release dipyridamole 200 mg per capsule; historical 60-count repackaged pack; image is a repackager label, not the originator carton or current stockNDC 54868-5143-0 (source NDC 0597-0001)
  • Aspirin 25 mg plus extended-release dipyridamole 200 mg per capsule; 30-count bottle; this is a current generic comparator, not an AGGRENOX originator-brand packNDC 68462-405-30
  • Aspirin 25 mg plus extended-release dipyridamole 200 mg per capsule; 60-count bottle; this is a current generic comparator, not an AGGRENOX originator-brand packNDC 68462-405-60

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-06
Source record
6 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image